...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith AGM Tuesday 12/12 2:45 MT

"Following the formal business of the Meeting, Mr. Donald J. McCaffrey, President and Chief Executive Officer, will deliver a corporate update presentation. The presentation will be available via live webcast." 

Share
New Message
Please login to post a reply